Medication info
Osobon Tablets (Osobon Substance)

Osobon Tablets (Osobon Substance)

OTC medicationTabletOral
Ingredient · strength
Ossopan Substance›830mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Oval-shaped yellow film-coated tablet
Packaging
100 tablets (10 tablets/PTP*10), 300 tablets/bottle
Approval status
Active

MFDS item code 199703205 · Notified 1997.05.08

Summary

Main use
Nutritional improvement through calcium and phosphorus supplementation for osteoporosis, fracture healing, and during pregnancy and lactation
Who takes it
Adults
Adult dose
○ Osteoporosis: As Osseopan, adults should take 1660∼3320 mg per dose twice daily. ○ Other indications: As this medicine, adults should take 830∼1660 mg per dose once daily. Take before meals with a beverage.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Nutritional improvement through calcium and phosphorus supplementation for osteoporosis, fracture healing, and during pregnancy and lactation

  • Osteoporosis
  • fracture healing
View approved original text

This medication helps to supply calcium and phosphorus to promote osteoporosis and fracture healing. It is also used to support the supply of calcium and phosphorus for women during pregnancy or breastfeeding to maintain health.

How to take

Adult dose

○ Osteoporosis: As Osseopan, adults should take 1660∼3320 mg per dose twice daily. ○ Other indications: As this medicine, adults should take 830∼1660 mg per dose once daily. Take before meals with a beverage.

Precautions

This medication should not be taken by patients with hypercalcemia (excessive calcium in the blood), sarcoidosis, or kidney disease. Patients with hypercalciuria (excessive calcium in urine) or kidney stones should also avoid using this medication. Individuals with allergic reactions or hypersensitivity to any component in this medication should refrain from taking it. This medication should not be used for infants under 12 months old, i.e., newborns or breastfed babies. Patients with severe renal failure should also not take this medication. During the time of using this medication, it is advisable not to take tetracycline antibiotics or drugs like phosphates, calcium salts, and antacids together, and if necessary, they should be taken at least 4 hours apart. This medication contains a pigment called Yellow No. 4 (Tartrazine), and caution should be taken if allergic or hypersensitive to this ingredient. While taking this medication, it is advisable to avoid teas rich in tannins such as green tea or black tea. Patients receiving treatment or those who are unable to move, including those with heart or circulatory disorders, kidney disorders, and hypoproteinemia, should consult a physician or pharmacist before using this medication. Additionally, individuals taking high doses of vitamin D or calcium, sodium fluoride, anti-aldosterone agents, triamterene, or thiazide diuretics should also consult a specialist before using this medication. If symptoms like constipation, low blood pressure, flushing, irregular heartbeat, nausea, vomiting, skin rash occur during the use of this medication, it is essential to stop taking it immediately and consult a physician or pharmacist. Long-term use may lead to hypercalcemia or the formation of stones, so caution is needed. This medication must be used strictly according to the prescribed dosage and regimen, and especially for children, it should be administered under the supervision of a guardian. If symptoms do not improve or worsen after 1 month, consult a professional immediately. Keep this medication out of reach of children, store it away from direct sunlight, and in a dry and cool place. It is also advisable not to transfer medication from its original container to another container and to store it securely in its original container.

Side effects

  • Constipation
  • hypotension
  • facial flushing
  • arrhythmia
  • nausea
  • vomiting
  • skin rash
  • hypercalcemia
  • stones
  • gastrointestinal symptoms
Show 3 more
  • hypernatremia
  • congestive heart failure
  • edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Oval-shaped yellow film-coated tablet

Package unit

100 tablets (10 tablets/PTP*10), 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.